Management and investigation of neonatal thromboembolic events: Genetic and acquired risk factors

P. Saracco, E. Parodi, C. Fabris, V. Cecinati, A. C. Molinari, P. Giordano

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Newborns comprise the largest group of children developing thromoboembolic events (TE S), due to the peculiarities of their developmental hemostatic system. Moreover, in the sick newborn, especially preterm, numerous acquired perinatal and iatrogenic conditions might result in a disturbance between coagulation and fibrinolysis, leading to thrombus formation. Nevertheless, the contribution of acquired prothrombotic disorders in the pathogenesis of thromboembolic disease in newborns remains poorly defined. Few data are currently available regarding the influence of maternal or fetal genes on thrombotic risk in the fetus and neonate. Ongoing National and International registries are partially answering these questions. The purpose of this review is to evaluate the current knowledge about the role of inherited, acquired perinatal and maternal prothrombotic risk factors in neonatal cerebral nervous system (CNS) thrombotic events and non-CNS thrombotic events.

Original languageEnglish
Pages (from-to)805-809
Number of pages5
JournalThrombosis Research
Volume123
Issue number6
DOIs
Publication statusPublished - Apr 2009

Fingerprint

Newborn Infant
Nervous System
Mothers
Fibrinolysis
Hemostatics
Registries
Fetus
Thrombosis
Genes

Keywords

  • Maternal
  • Newborn
  • Risk factors
  • Stroke
  • Thrombophilia
  • Thrombosis

ASJC Scopus subject areas

  • Hematology

Cite this

Management and investigation of neonatal thromboembolic events : Genetic and acquired risk factors. / Saracco, P.; Parodi, E.; Fabris, C.; Cecinati, V.; Molinari, A. C.; Giordano, P.

In: Thrombosis Research, Vol. 123, No. 6, 04.2009, p. 805-809.

Research output: Contribution to journalArticle

Saracco, P. ; Parodi, E. ; Fabris, C. ; Cecinati, V. ; Molinari, A. C. ; Giordano, P. / Management and investigation of neonatal thromboembolic events : Genetic and acquired risk factors. In: Thrombosis Research. 2009 ; Vol. 123, No. 6. pp. 805-809.
@article{60144e5aa745451999beb254abdb51d3,
title = "Management and investigation of neonatal thromboembolic events: Genetic and acquired risk factors",
abstract = "Newborns comprise the largest group of children developing thromoboembolic events (TE S), due to the peculiarities of their developmental hemostatic system. Moreover, in the sick newborn, especially preterm, numerous acquired perinatal and iatrogenic conditions might result in a disturbance between coagulation and fibrinolysis, leading to thrombus formation. Nevertheless, the contribution of acquired prothrombotic disorders in the pathogenesis of thromboembolic disease in newborns remains poorly defined. Few data are currently available regarding the influence of maternal or fetal genes on thrombotic risk in the fetus and neonate. Ongoing National and International registries are partially answering these questions. The purpose of this review is to evaluate the current knowledge about the role of inherited, acquired perinatal and maternal prothrombotic risk factors in neonatal cerebral nervous system (CNS) thrombotic events and non-CNS thrombotic events.",
keywords = "Maternal, Newborn, Risk factors, Stroke, Thrombophilia, Thrombosis",
author = "P. Saracco and E. Parodi and C. Fabris and V. Cecinati and Molinari, {A. C.} and P. Giordano",
year = "2009",
month = "4",
doi = "10.1016/j.thromres.2008.12.002",
language = "English",
volume = "123",
pages = "805--809",
journal = "Thrombosis Research",
issn = "0049-3848",
publisher = "Elsevier Limited",
number = "6",

}

TY - JOUR

T1 - Management and investigation of neonatal thromboembolic events

T2 - Genetic and acquired risk factors

AU - Saracco, P.

AU - Parodi, E.

AU - Fabris, C.

AU - Cecinati, V.

AU - Molinari, A. C.

AU - Giordano, P.

PY - 2009/4

Y1 - 2009/4

N2 - Newborns comprise the largest group of children developing thromoboembolic events (TE S), due to the peculiarities of their developmental hemostatic system. Moreover, in the sick newborn, especially preterm, numerous acquired perinatal and iatrogenic conditions might result in a disturbance between coagulation and fibrinolysis, leading to thrombus formation. Nevertheless, the contribution of acquired prothrombotic disorders in the pathogenesis of thromboembolic disease in newborns remains poorly defined. Few data are currently available regarding the influence of maternal or fetal genes on thrombotic risk in the fetus and neonate. Ongoing National and International registries are partially answering these questions. The purpose of this review is to evaluate the current knowledge about the role of inherited, acquired perinatal and maternal prothrombotic risk factors in neonatal cerebral nervous system (CNS) thrombotic events and non-CNS thrombotic events.

AB - Newborns comprise the largest group of children developing thromoboembolic events (TE S), due to the peculiarities of their developmental hemostatic system. Moreover, in the sick newborn, especially preterm, numerous acquired perinatal and iatrogenic conditions might result in a disturbance between coagulation and fibrinolysis, leading to thrombus formation. Nevertheless, the contribution of acquired prothrombotic disorders in the pathogenesis of thromboembolic disease in newborns remains poorly defined. Few data are currently available regarding the influence of maternal or fetal genes on thrombotic risk in the fetus and neonate. Ongoing National and International registries are partially answering these questions. The purpose of this review is to evaluate the current knowledge about the role of inherited, acquired perinatal and maternal prothrombotic risk factors in neonatal cerebral nervous system (CNS) thrombotic events and non-CNS thrombotic events.

KW - Maternal

KW - Newborn

KW - Risk factors

KW - Stroke

KW - Thrombophilia

KW - Thrombosis

UR - http://www.scopus.com/inward/record.url?scp=63049092699&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=63049092699&partnerID=8YFLogxK

U2 - 10.1016/j.thromres.2008.12.002

DO - 10.1016/j.thromres.2008.12.002

M3 - Article

C2 - 19167028

AN - SCOPUS:63049092699

VL - 123

SP - 805

EP - 809

JO - Thrombosis Research

JF - Thrombosis Research

SN - 0049-3848

IS - 6

ER -